Indeed, while CD47 is only rarely expressed in non-metastatic tumors, we find it highly expressed on at least some CTCs of all breast cancer patients analyzed as well as in metastatic tumors and in all human CTC-induced metastases in xenografts (this study and [41]). Here, CD47 is linked to breast cancer.